Closed carolinehey closed 6 months ago
Hello Caroline,
I have included in the very beginning the cMAD feature to use it as a mesure of quality. That part of the code is from very old time. The cMAD variable is deprecated (first snipplet) to the _QC_MAD_pointcorrected calculation. With it, I defined the first rule as previously described in the Bioinformatics report.
It is the variable _QC_MAD_pointcorrected that is used in the final table, not the cMAD !
a = c("CNA cut-off value", "Number simulations for cut-off", "Number successfull simulations", "MAX2", "cMAD", "Number LGAs 10Mb", "HRD")
b = c(THR, format(nb_simulations,scientific = F), number_positive, round(MAX2,3), QC_MAD_point_corrected, number_LGAs, HRD)
This criteria was somewhat satisfying at the time but I changed since then the pipeline, relying on random sampling to insure a better CNA cut-off detection.
For this version 1.13 (not the 2.0), good quality indicators are :
I would rely more on them. hope I clarified the "cMAD inclusion part" that should not be there.
Is it clear for you ?
Best regards, Alexandre Eeckhoutte
Thank you very much for your answer, it is much more clear to me now :)
I have a question about the cMAD that i hope you can anwser. I the shallowHRD_hg19_1.13_QDNAseq_no_chrX.R code i found this snippet: However, further up in the script i see thresholds matching what is specified in the Bioinformatic report:
Are these cMAD/QC_MAD_point_corrected supposed to be the same, and classified as bad >0.50 or 0.05 ? Finally, there is also a threshold cMAD<0.14 is good.
I am a bit confused and hope you can clarify this.
Kind regards, Caroline